Aclaris Therapeutics Inc Stock Performance
as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
$1.83$1.95
0.54%
Downside
5.98%
Upside
52 Week's Low
52 Week's High
$1.05$5.1742.93%
Downside
180.98%
Upside
Aclaris Therapeutics Inc share price movements today
- Previous Close
- $1.95
- Open
- $1.94
- Volume
- 1.5M
- Day's Low - High
- $1.83 - $1.95
- 52 Week Low - High
- $1.05 - $5.17
Aclaris Therapeutics Inc Historical Returns
- 1 Month Return
- + 4.28 %
- 3 Month Return
- + 32.65 %
- 1 Year Return
- + 65.25 %
- 3 Year Return
- -86.45 %
- 5 Year Return
- -17.02 %
Aclaris Therapeutics Inc Stock Fundamentals & Key Indicators
Check Aclaris Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$211.2M
EPS (TTM)
-0.525
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.42
Industry PE ratio
-3.8535542168674697
P/B Ratio
0PEG Ratio
-0.13
EBITDA
-58.3M
Revenue (TTM)
16.8M
Profit Margin
0.00%
Return On Equity TTM
9268500.00%
Aclaris Therapeutics Inc Stock Valuation
Track how Aclaris Therapeutics Inc P/E has moved over time to understand its valuation trends.
Aclaris Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Industry (-3.85x)
September 15, 2025
Today (-1.42x)
September 15, 2025
Highest (-0.99x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.42x
Aclaris Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aclaris Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $211.2M | -17.02% | -1.42 | 0.00% | |
| BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
| BUY | $59.4B | -3.43% | 14.11 | 31.37% |
Stock Returns calculator for Aclaris Therapeutics Inc Stock including INR - Dollar returns
The Aclaris Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aclaris Therapeutics Inc investment value today
Current value as on today
₹1,60,918
Returns
₹60,918
(+60.92%)
Returns from Aclaris Therapeutics Inc Stock
₹55,932 (+55.93%)
Dollar Returns*
₹4,985 (+4.99%)
Analyst Recommendation on Aclaris Therapeutics Inc Stock
Based on 15 analysts
40.00%
Buy
60.00%
Hold
0.00%
Sell
Based on 15 analysts, 60% of analysts recommend a 'HOLD' rating for Aclaris Therapeutics Inc. Average target price of $7.86
Aclaris Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Aclaris Therapeutics Inc.
What analysts predicted
76.59%UPSIDE
Target Price
$7.86
Current Price
$1.84
Analyzed by
15 Analysts
Target
$7.86
Aclaris Therapeutics Inc target price $7.86, a slight upside of 76.59% compared to current price of $1.84. According to 15 analysts rating.
Aclaris Therapeutics Inc Stock's Interest Amongst Investors
Search interest for Aclaris Therapeutics Inc Stock has increased by 127% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:127% versus previous 30 day period
Aclaris Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Aclaris Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Aclaris Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Aclaris Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Aclaris Therapeutics Inc
Insights on Aclaris Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 1.45M → 1.77M (in $), with an average increase of 18.1% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 209.9%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 10.3%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -15.08M → -15.42M (in $), with an average decrease of 2.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, ACRS stock has moved down by -6.3%
About Aclaris Therapeutics Inc
| Organisation | Aclaris Therapeutics Inc |
| Headquarters | 701 Lee Road, Wayne, PA, United States, 19087 |
| Industry | Health Technology |
| CEO | Dr. Neal S. Walker D.O., M.D. |
| E-voting on shares | Click here to vote |
Key Management of Aclaris Therapeutics Inc
Name | Title |
|---|---|
Dr. Neal S. Walker D.O., M.D. | Co-Founder, CEO & Chairman |
Dr. Hugh M. Davis Ph.D. | President, COO & Director |
Dr. Roland Kolbeck Ph.D. | Chief Scientific Officer |
Mr. William C. Roberts | Senior VP of Corporate Communications & Investor Relations |
Mr. James Loerop | Chief Business Officer |
Mr. Ajay Aggarwal M.B.A., M.D. | Senior Vice President of Clinical Development |
Mr. Kevin Balthaser | Chief Financial Officer |
Mr. Matthew Rothman J.D. | General Counsel & Corporate Secretary |
Dr. Jon Jacobsen Ph.D. | Senior Vice President of Chemistry |
Mr. Steve Tucker | Executive Vice President of Project Leadership |
FAQs
What is Aclaris Therapeutics Inc share price today?
Aclaris Therapeutics Inc share price today is $1.84 as on at the close of the market. Aclaris Therapeutics Inc share today touched a day high of $1.95 and a low of $1.83.
What is the 52 week high and 52 week low for Aclaris Therapeutics Inc share?
Aclaris Therapeutics Inc share touched a 52 week high of $5.17 on and a 52 week low of $1.05 on . Aclaris Therapeutics Inc stock price today i.e. is closed at $1.84,which is 64.41% down from its 52 week high and 75.24% up from its 52 week low.
What is Aclaris Therapeutics Inc's market capitalisation today?
Aclaris Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Aclaris Therapeutics Inc Stock (ACRS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aclaris Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aclaris Therapeutics Inc Shares that will get you 0.8152 shares as per Aclaris Therapeutics Inc share price of $1.84 per share as on September 16, 2025 at 1:29 am IST.
What is the minimum amount required to buy Aclaris Therapeutics Inc Stock (ACRS) from India?
Indian investors can start investing in Aclaris Therapeutics Inc (ACRS) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Aclaris Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aclaris Therapeutics Inc share’s latest price of $1.84 as on September 16, 2025 at 1:29 am IST, you will get 5.4348 shares of Aclaris Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Aclaris Therapeutics Inc has given to Indian investors in the last 5 years?
Aclaris Therapeutics Inc stock has given -17.02% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?